原著論文(英文)


1.Role of RFRP-3 in the Regulation of Kiss-1 Gene Expression in the AVPV Hypothalamic Cell Model mHypoA-50.
Kanasaki H, Tumurbaatar T, Oride A, Tumurgan Z, Okada H, Hara T, Tsutsui K, Kyo S.
Reprod Sci  1933719118813456, 2018.


2.High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
Ishikawa M, Nakayama K, Nakamura K, Ono R, Yamashita H, Ishibashi T, Minamoto T, Iida K, Razia S, Ishikawa N, Kyo S.
Hum Pathol  S0046-8177(18)30424-6, 2018.

3.Prognostic significance of pre-treatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in non-surgically treated uterine cervical carcinoma.
Nakamura K, Nakayama K, Tatsumi N, Minamoto T, Ishibashi T, Ohnishi K, , Yamashita H, Ono R, Sasamori H, Razia S, Kamrunnahar S, Ishikawa M, Kyo S.
Mol Clin Oncol 9(2):138-144, 2018.


4.Role of pituitary adenylate cyclase-activating polypeptide in modulating hypothalamic-pituitary system.
Oride A, Kanasaki H, Kyo S.
Reprod Med Biol 31;17(3):234-241, 2018.


5.Cancer-related transcription regulator protein NAC1 forms a protein complex with CARM1 for ovarian cancer progression.
Nakayama N, Sakashita G, Nariai Y, Kato H, Sinmyozu K, Nakayama JI,
Kyo S, Urano T, Nakayama K.
Oncotarget 19;9(47):28408-28420, 2018.


6.Action of Neurotensin, CRH, and RFRP-3 in E2-induced Negative Feedback Control: Studies Using a Mouse ARC Hypothalamic Cell Model.
Tumurbaatar T, Kanasaki H, Oride A, Hara T, Okada H, Tsutsui K, Kyo S.
Biol Reprod  doi: 10.1093/biolre/ioy145, 2018.


7.ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.
Sato E, Nakayama K, Razia S, Nakamura K, Ishikawa M, Minamoto T, Ishibashi T, Yamashita H, Iida K, Kyo S.
Int J Mol Sci 19(6), 2018.


8.Comparison of Postoperative Short-Term Outcomes between Tension-Free Vaginal Mesh Surgery Using the Capio™ SLIM Suture Capturing Device and Conventional TVM Surgery for Pelvic Organ Prolapse.
Kanasaki H, Oride A, Hara T, Kyo S.
Obstet Gynecol Int 2018:7918071, 2018.


9.Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma.
Nakamura K, Nakayama K, Ishikawa N, Minamoto T, Ishibashi T, Ohnishi K, Yamashita H, Ono R, Sasamori H, Razia S, Hossain MM, Kamrunnahar S, Ishikawa M, Kyo S.
Oncotarget, 9(33):23164-23172, 2018.


10.Genetic analysis and the status of PI3K/AKT pathway in ovarian endometrioid borderline tumor samples.
Nakamura K, Nakayama K, Ishikawa M, Minamoto T, Ishibashi T, Sato E, Sanuki K, Yamashita H, Ono R, Iida K, Sultana R, Hossain MM, Ishikawa N, Kyo S.
Oncol Lett 16(1):189-194 ,2018.


11.GnRH agonist pretreatment for microwave endometrial ablation in women with less than 1 cm myometrial thickness.
Nakamura K, Nakayama K, Ishikawa M, Katagiri A, Katagiri H, Ishibashi T , Sato E, Kyo S.
J Obstet Gynaecol 21:1-3, 2018.


12.Affinity purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients.
Ishikawa M, Nakayama K, Nakamura K, Ono R, Sanuki K, Yamashita H, Ishibashi T, Minamoto T, Razia S, Iida K, Ishikawa N, Kyo S.
Oncotarget. 9:14754-14763, 2018. 


13.Loss of beclin 1 expression in ovarian cancer: a potential biomarker to predict unfavorable outcome.
Minamoto T, Nakayama K, Nakamura K, Katagiri H, Sultana R, Ishibashi T, Ishikawa M, Yamashita H, Sanuki K, Iida K, Nakayama S, Otsuki Y, Ishikawa N, Kyo S.
Oncol Lett 15:1170-1176, 2018.


14.High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma.
Nakamura K, Nakayama K, Minamoto T, Ishibashi T, Sanuki K, Yamashita H, Ono R, Sasamori H, Komatsu-Fujii T, Ishikawa M, Kyo S.
Mol Clin Oncol 8:429-433, 2018.

 

症例報告


15.Ultrasound-guided intranodal lymphangiography with lipiodol for treatment of chylous ascites following surgery for ovarian cancer: A case report.
Nakamura K, Nakayama K, Minamoto T, Ishibashi T, Ohnishi K, Yamashita H, Ono R, Sasamori H, Razia S, Kamrunnahar S, Ishikawa M, Kyo S.
Mol Clin Oncol 9(2):178-180, 2018.


16.Lynch Syndrome-Related Clear Cell Carcinoma of the Cervix: A Case Report.
Nakamura K, Nakayama K, Minamoto T, Ishibashi T, Ohnishi K, Yamashita H, Ono R, Sasamori H, Razia S, Hossain MM, Kamrunnahar S, Ishikawa M , Ishikawa N, Kyo S.
Int J Mol Sci 19(4), 2018.